ISSN 1662-4009 (online)

ESPE Yearbook of Paediatric Endocrinology (2022) 19 8 | DOI: 10.1530/ey.19.8
0
Err

1Department of Women´s and Children´s Health, Pediatric Endocrinology Unit Karolinska University Hospital/Karolinska Institutet, 171 76 Stockholm, Sweeden; 2Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, ‘Aghia Sophia’ Children’s Hospital, Athens, 11527, Greece; 3Division of Endocrinology and Metabolism, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, 11527, Greece
* Equal author contribution
Author for Correspondence: Evangelia Charmandari, MD, MSc, PhD, MRCP(UK), CCST(UK), Professor of Pediatric and Adolescent Endocrinology, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, ‘Aghia Sophia’ Children’s Hospital, Thivon and Papadiamantopoulou Street, Athens, 11527, Greece, Tel/Fax: +30-213-2013 384 Email: evangelia.charmandari@googlemail.com


Preface: For this year’s chapter, we searched PubMed for articles on ‘adrenal’ or ‘steroidogenesis’ published in English between June 1, 2021 and May 31, 2022. Our search yielded more than 5,000 citations. We examined all citations individually and selected the following collection of basic research and clinical articles. Whenever possible, we have avoided topics that have been discussed in the Yearbook 2021, unless progress in the field has been incremental. Emerging themes for this year’s chapter include: i) The developmental origin and the specification of the adrenal cortex in humans and cynomolgus monkeys; ii) Corticosterone induces discrete epigenetic signatures in the dorsal and ventral hippocampus that depend upon sex and genotype: focus on methylated NR3C1 gene; iii) A multi-classifier system to identify and subtype congenital adrenal hyperplasia based on circulating steroid hormones; iv) Crinecerfont lowers elevated hormone markers in adults with 21-hydroxylase deficiency Congenital Adrenal Hyperplasia; and v) results from two phase 2 studies of Tildacerfont in adults with classic Congenital Adrenal Hyperplasia.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

Adrenals (<1 min ago)